Article ID Journal Published Year Pages File Type
2093422 Stem Cell Reports 2015 12 Pages PDF
Abstract

•Fibroblasts from two Sanfilippo C patients were reprogrammed to obtain iPSCs•iPSCs were successfully differentiated to neural cells that mimic the disease•Networks of patients’ neurons show altered activity and connectivity•Early functional phenotypes are prevented in gene-corrected patients’ neurons

SummaryInduced pluripotent stem cell (iPSC) technology has been successfully used to recapitulate phenotypic traits of several human diseases in vitro. Patient-specific iPSC-based disease models are also expected to reveal early functional phenotypes, although this remains to be proved. Here, we generated iPSC lines from two patients with Sanfilippo type C syndrome, a lysosomal storage disorder with inheritable progressive neurodegeneration. Mature neurons obtained from patient-specific iPSC lines recapitulated the main known phenotypes of the disease, not present in genetically corrected patient-specific iPSC-derived cultures. Moreover, neuronal networks organized in vitro from mature patient-derived neurons showed early defects in neuronal activity, network-wide degradation, and altered effective connectivity. Our findings establish the importance of iPSC-based technology to identify early functional phenotypes, which can in turn shed light on the pathological mechanisms occurring in Sanfilippo syndrome. This technology also has the potential to provide valuable readouts to screen compounds, which can prevent the onset of neurodegeneration.

Graphical AbstractFigure optionsDownload full-size imageDownload as PowerPoint slide

Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Biotechnology
Authors
, , , , , , , , , , , ,